BIOMEDICAL TREATMENT OF THE YOUNG ADULT WITH AUTISM SPECTRUM DISORDER
Adrenals and a Review of Other ...
By AutismOne, 11 years 35 weeks agoAO/GR 2012 Conference. Rachel West, DO, FACOP.
Is There an Intervention That ...
By AutismOne, 11 years 35 weeks agoAO/GR 2012 Conference. Theoharis C. Theoharides, PhD, MD, FAAAAI.
Are Stem Cells the Future of Autism ...
By AutismOne, 11 years 35 weeks agoAO/GR 2012 Conference. Jeff Bradstreet, MD.
TACA Real Help Now Conference in Madison, WI
Real Help Now Conference in Madison, WI
February 27, 2010, 8am – 5pm
Madison Candlewood Suites,
5421 Caddis Bend, Madison, WI
Speakers include world-renowned biomedical experts:
•Lauren Underwood, Ph.D. – Biomedical and Behavioral Therapies Together: A Best Practice Model for Treating Autism
•Kyle Van Dyke, M.D. – Oxidative Stress and Inflammation in Autism
•Anju Usman, M.D. – The Gut-Brain-Immune Connection
Mitochondrial Dysfunction (MtD): Diagnosis, Analysis and Treatment
This interactive lecture is geared to both children who are suspected of having MtD and to children who have already been diagnosed. Tools will be provided which will allow the majority of parents to determine the likelihood of MtD in their child as unlikely, possible, probable or definite. For children who already have a diagnosis of MtD, an in-depth analysis of the medical literature will review treatment options. If possible, bring test results for lactic acid, alanine and lactate/pyruvate ratio. Attendees will leave with a workbook and a plan of action.
Daniel A. Rossignol, MD, FAAFP
Dr. Rossignol received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. He is currently a physician at ICDRC in Melbourne, FL. Coming from an academic background, Dr. Rossignol searched the medical literature looking for a solution after both of his children were diagnosed with autism. Finding no obvious solution, he made it his mission to research and publish in autism. In the last 5 years, he has published 8 papers as the lead author for a total of 14 papers on autism with 5 more to be published this year. He has also written 3 book chapters on autism. Dr Rossignol received the prestigious Edgar End Memorial Award from the Undersea Hyperbaric Medical Society for his pioneering paper in hyperbaric research in autism.
Metabolic Abnormalities: Analysis and New Treatments
This lecture examines autism through a different lens—from a metabolic standpoint. Dr. Rossignol takes the classic problems of oxidative stress, mitochondrial dysfunction, immune dysregulation, impaired methylation, seizures and cerebral folate deficiency and addresses them metabolically. He will also discuss his ongoing IRB approved research in metabolic contributors to autism scheduled to be published later this year. Families and physicians dealing with both “tough-nuts” and newly diagnosed children will gain unique insights into metabolic testing and cutting-edge treatments.
Daniel A. Rossignol, MD, FAAFP
Dr. Rossignol received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. He is currently a physician at ICDRC in Melbourne, FL. Coming from an academic background, Dr. Rossignol searched the medical literature looking for a solution after both of his children were diagnosed with autism. Finding no obvious solution, he made it his mission to research and publish in autism. In the last 5 years, he has published 8 papers as the lead author for a total of 14 papers on autism with 5 more to be published this year. He has also written 3 book chapters on autism. Dr Rossignol received the prestigious Edgar End Memorial Award from the Undersea Hyperbaric Medical Society for his pioneering paper in hyperbaric research in autism.
Remarkable Findings of Auto-antibodies: Testing and Treatment
New data shows that many children with autism and their parents produce auto-antibodies to a folate receptor which can lead to a condition called Cerebral Folate Deficiency (CFD). Multiple studies have shown CFD can cause autism, seizures, mitochondrial disease, motor abnormalities or other neurological problems. Dr. Rossignol will review recent studies and research on testing for these antibodies and innovative treatments that are typically covered by insurance. He will also discuss his current IRB approved study he is conducting with Dr. Richard Frye. Case studies treated by Dr.
Daniel A. Rossignol, MD
Dr. Rossignol received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. He is currently a physician at ICDRC in Melbourne, FL. Coming from an academic background, Dr. Rossignol searched the medical literature looking for a solution after both of his children were diagnosed with autism. Finding no obvious solution, he made it his mission to research and publish in autism. In the last 5 years, he has published 8 papers as the lead author for a total of 14 papers on autism with 5 more to be published this year. He has also written 3 book chapters on autism. Dr Rossignol received the prestigious Edgar End Memorial Award from the Undersea Hyperbaric Medical Society for his pioneering paper in hyperbaric research in autism.
Biomedical Interventions Put to the Test –Autism Reality For Physicians and Parents / Plus Aid for Autism Movie
Come see what happens when a Biomedical approach for the treatment of Autism is applied in real life. The Reese family, under the guidance of Dan Rossignol, M.D. agreed to have their life documented and videoed as they took their treatment naive son, Julius (4 yrs old), through one full year of biomedical therapies. The results were astounding. Aid For Autism took this mission on to motivate parents, physicians and lawmakers and show them what it takes personally and financially to treat autism.
Celeste Reese
Celeste Reese is the Mother to Julius, a 4 year old boy with Autism. Pushed to the brink of exhaustion, Celeste became overwhelmed and collapsed at a conference where she heard about biomedical therapies and the successes physicians and parents were seeing in their children with Autism. Celeste shares her struggles, accomplishments, and reactions to various physical and biomedical therapies in her blog on aidforautism.com and provides helpful insight into a life driven towards recovery.
Daniel A. Rossignol, MD, FAAFP
Dr. Rossignol received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. He is currently a physician at ICDRC in Melbourne, FL. Coming from an academic background, Dr. Rossignol searched the medical literature looking for a solution after both of his children were diagnosed with autism. Finding no obvious solution, he made it his mission to research and publish in autism. In the last 5 years, he has published 8 papers as the lead author for a total of 14 papers on autism with 5 more to be published this year. He has also written 3 book chapters on autism. Dr Rossignol received the prestigious Edgar End Memorial Award from the Undersea Hyperbaric Medical Society for his pioneering paper in hyperbaric research in autism.
Interactive Q&A with Leading Physicians and Parents
Join us for a Q&A with a panel of the most published and most successful biomedical experts leading the field of Autism Spectrum Disorders coupled with parents who are actively utilizing biomedical interventions to help their children. Make the most of this rare opportunity and have your questions prepared. You will have the chance to learn from other parents' stories and concern, and have the chance for all these leading physicians weigh in on these issues.
Dan Rossignol, MD, FAAFP
Dr. Rossignol received his MD degree at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. After both his children were diagnosed with autism, he made it his mission to research and publish on autism. Since 2006, he has 23 publications and 3 book chapters concerning autism and related conditions. He is a Fellow of the American Academy of Family Physicians (FAAFP) and is president of the Medical Academy of Pediatric Special Needs (MAPS).
Richard E. Frye, MD, PhD
Richard Frye, MD, PhD is the Director of Autism Research and Associate Professor of Pediatrics at The University of Arkansas for Medical Sciences. He specializes in pediatric neurology disorders, including learning disabilities and dyslexia, autism, speech and language delay, attention deficit, tics and Tourette’s syndrome, sleep disorders, and epileptic encephalopathy. Dr. Frye is board certified in pediatrics and neurology and completed fellowships in behavioral neurology and psychology.
David Dornfeld, DO
David Dornfeld, DO, has been practicing Family Medicine for twenty-three years, with extensive experience covering the full spectrum of clinical Family Medicine. He has developed a special interest in working with children that have Autism Spectrum Disorders. His experience encompasses all spectrums of Family Medicine, Spinal manipulation, Chelation Therapy, IV Infusion Therapy and Hyperbaric Therapies.
Kyle Van Dyke, MD
Kyle Van Dyke recieved his MD from the University of Chicago and completed his redsidency in Family Medicine at the University of Virginia. He is board certified in Family Medicine. He became involved in autism after the diagnosis of his son 7 years ago. His interests include clinical interventions, mitochondria, and hyperbaric therapy.
James Neubrander, MD
Dr. Neubrander graduated from medical school in 1975, is board certified in Environmental Medicine, the medical director of two entities, scientific advisor to several organizations, and a well-known speaker nationally and internationally. Since the mid-90s he has treated 4000-5000 children on the autism spectrum. He is known as the Father of Methyl-B12 and the innovator of HBOT protocols used to treat children with autism and other disorders.
